SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Amgen Receives Complete Response Letter For Extended Dosing Of Aranesp(R) For Patients With Chronic Kidney Disease And Anemia; FDA Seeks More Data